Autoscribe Opens Office to Support Expanding BioHub
News Oct 23, 2015
Based in Alderley Park in Cheshire the office will supply and support laboratory and business information systems management to customers across the north of the country.
Established by AstraZeneca the BioHub in Alderley Park acts as a bioscience incubator for over 100 pharmaceutical and life science Companies. It allows them to take advantage of the world class facilities at Alderley Park including laboratories with access to high end equipment through AstraZeneca, as well as on-site business support and staff facilities including a gym and restaurant.
“Our new northern office in Alderley Park allows us to better serve our expanding list of Laboratory Informatics Management System (LIMS) customers across the UK. It’s exciting to be part of the vibrant and fast expanding ecosystem of businesses in the Biohub, all of which will require laboratory management solutions as their businesses expand” said John Boother, Managing Director of Autoscribe Informatics. “Our Matrix Gemini LIMS solution is ideal for businesses in the Biohub as it easily scales from a single seat to global deployment, while its legendary configurability enables it to be easily adapted to suit changing business needs”.
The Genes That Make Quorn a Fungal Food FavoriteNews
The meat substitute Quorn is derived from a fungus called Fusarium venenatum. A very similar fungus, F. graminearum, is one of the world's most damaging crop diseases. A new genome study shows why one fungus makes food, and the other destroys it.READ MORE
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018